Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Pisa syndrome due to donepezil: pharmacokinetic interactions to blame? - Pollock_2017_Age.Ageing_46_529 |
| Author(s) : Pollock D , Cunningham E , McGuinness B , Passmore AP |
| Ref : Age Ageing , 46 :529 , 2017 |
| Abstract : Pollock_2017_Age.Ageing_46_529 |
| ESTHER : Pollock_2017_Age.Ageing_46_529 |
| PubMedSearch : Pollock_2017_Age.Ageing_46_529 |
| PubMedID: 28104598 |
| Title : Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease - Patterson_2011_Pharmacogenomics.J_11_444 |
| Author(s) : Patterson CE , Todd SA , Passmore AP |
| Ref : Pharmacogenomics J , 11 :444 , 2011 |
| Abstract : Patterson_2011_Pharmacogenomics.J_11_444 |
| ESTHER : Patterson_2011_Pharmacogenomics.J_11_444 |
| PubMedSearch : Patterson_2011_Pharmacogenomics.J_11_444 |
| PubMedID: 20644562 |
| Title : Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying? - Parsons_2010_Drugs.Aging_27_435 |
| Author(s) : Parsons C , Hughes CM , Passmore AP , Lapane KL |
| Ref : Drugs & Aging , 27 :435 , 2010 |
| Abstract : Parsons_2010_Drugs.Aging_27_435 |
| ESTHER : Parsons_2010_Drugs.Aging_27_435 |
| PubMedSearch : Parsons_2010_Drugs.Aging_27_435 |
| PubMedID: 20524704 |
| Title : Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials - Passmore_2005_J.Neurol.Sci_229-230_141 |
| Author(s) : Passmore AP , Bayer AJ , Steinhagen-Thiessen E |
| Ref : Journal of Neurology Sci , 229-230 :141 , 2005 |
| Abstract : Passmore_2005_J.Neurol.Sci_229-230_141 |
| ESTHER : Passmore_2005_J.Neurol.Sci_229-230_141 |
| PubMedSearch : Passmore_2005_J.Neurol.Sci_229-230_141 |
| PubMedID: 15760632 |
| Title : A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease - Wilkinson_2002_Int.J.Clin.Pract_56_441 |
| Author(s) : Wilkinson DG , Passmore AP , Bullock R , Hopker SW , Smith R , Potocnik FC , Maud CM , Engelbrecht I , Hock C , Ieni JR , Bahra RS |
| Ref : Int J Clin Pract , 56 :441 , 2002 |
| Abstract : Wilkinson_2002_Int.J.Clin.Pract_56_441 |
| ESTHER : Wilkinson_2002_Int.J.Clin.Pract_56_441 |
| PubMedSearch : Wilkinson_2002_Int.J.Clin.Pract_56_441 |
| PubMedID: 12166542 |
| Title : Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland - McIlroy_2000_J.Med.Genet_37_182 |
| Author(s) : McIlroy SP , Crawford VL , Dynan KB , McGleenon BM , Vahidassr MD , Lawson JT , Passmore AP |
| Ref : Journal of Medical Genetics , 37 :182 , 2000 |
| Abstract : McIlroy_2000_J.Med.Genet_37_182 |
| ESTHER : McIlroy_2000_J.Med.Genet_37_182 |
| PubMedSearch : McIlroy_2000_J.Med.Genet_37_182 |
| PubMedID: 10699053 |
| Title : Acetylcholinesterase inhibitors in Alzheimer's disease - |
| Author(s) : McGleenon BM , Dynan KB , Passmore AP |
| Ref : British Journal of Clinical Pharmacology , 48 :471 , 1999 |
| PubMedID: 10583015 |